Abstract: An antibody or antigen binding fragment thereof that specifically binds to an epitope in a SEMA domain of c-Met protein, and pharmaceutical compositions, methods, kits, nucleic acids, and cells related thereto.

Abstract: Methods and compositions for treating inflammatory or autoimmune diseases in a subject comprising blocking the interaction between DR3 and TL1A. In the methods of treating inflammatory or autoimmune disease, the inflammatory or autoimmune disease can be an autoimmune disease with a T cell component, including asthma, multiple sclerosis, rheumatoid arthritis, type 1 diabetes, graft versus host disease or inflammatory bowel disease.

Abstract: A transmitting apparatus generates a modulation pattern code corresponding to an input security key and modulates and transmits the bit stream with a corresponding modulation method for a duration of a corresponding modulation method while changing a modulation method according to the generated modulation pattern code.

Abstract: A biomarker for predicting and/or monitoring the efficacy of a c-Met inhibitor; a composition for predicting and/or monitoring the efficacy of a c-Met inhibitor, comprising a material detecting the biomarker; a composition for selecting a subject suitable for the application of a c-Met inhibitor, comprising a material detecting the biomarker; a method for predicting and/or monitoring the efficacy of a c-Met inhibitor using the biomarker; a method for selecting a subject suitable for the application of a c-Met inhibitor using the biomarker; and a method for preventing and/or treating cancer comprising administering a c-Met inhibitor to the selected subject.

Abstract: An apparatus of transmitting data in a multi-carrier system includes: a plurality of pulse-shaping filters for performing pulse shaping of incoming data symbols during a set pulse-shaping period; and a plurality of frequency converters convert signals that are pulse-shaped by the plurality of pulse-shaping filters into signals with frequency bands for a plurality of subcarriers.

Abstract: Provided are methods and compositions for treating inflammatory or autoimmune diseases in a subject comprising blocking the interaction between DR3 and TL1A. The interaction between DR3 and TL1A can be blocked by reducing expression of TL1A. The interaction between DR3 and TL1A can be blocked by administration of anti-DR3 antibodies. The interaction between DR3 and TL1A can be blocked by administration of anti-TL1A antibodies. In the methods of treating inflammatory or autoimmune disease, the inflammatory or autoimmune disease can be an autoimmune disease with a T cell component. In the methods of treating inflammatory or autoimmune disease, the inflammatory or autoimmune disease can be asthma, multiple sclerosis, rheumatoid arthritis, type 1 diabetes, graft versus host disease or inflammatory bowel disease (IBD).

Abstract: A method for prevention or treatment of a cancer, comprising co-administering (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib or a combination thereof, to a subject in need thereof, and a pharmaceutical composition comprising (a) an anti-c-Met antibody or an antigen-binding fragment thereof, and (b) at least one of lapatinib, regorafenib, vemurafenib, or a combination thereof are provided.

Abstract: An apparatus of transmitting data in a multi-carrier system includes: a plurality of pulse-shaping filters for performing pulse shaping of incoming data symbols during a set pulse-shaping period; and a plurality of frequency converters convert signals that are pulse-shaped by the plurality of pulse-shaping filters into signals with frequency bands for a plurality of subcarriers.

Abstract: A receiving terminal in a hybrid network receives a video stream through a broadcasting network. The receiving terminal receives a high speed video stream streamed at a high speed for a defined first period from a first time when switching from the broadcasting network to a communication network depending on a receiving state of the broadcasting network is determined, receives a live video stream streamed in a live form from any one time of the first period, and generates a continuous video stream using the video stream received through the broadcasting network, the high speed video stream, and the live video stream.

Abstract: A signal transmitting and receiving method and an apparatus for selecting an interference pattern from a security key and transmitting and receiving a signal based on the selected interference pattern are provided.

Abstract: Provided is a Multiple Input Multiple Output (MIMO) transmission method in a digital broadcasting system. The method includes generating a plurality of first modulation symbols by modulating first information bits; generating a plurality of second modulation symbols by modulating second information bits; generating a plurality of first pre-coded symbols and a plurality of second pre-coded symbols by pre-coding the plurality of first modulation symbols and the plurality of second modulation symbols; and allocating the plurality of first pre-coded symbols and the plurality of second pre-coded symbols staggeringly through a first antenna and a second antenna and transmitting them.

Abstract: Disclosed are an anti-idiotype antibody that specifically binds to an idiotope site of an anti-c-Met antibody, the use of the anti-idiotype antibody for detecting the anti-c-Met antibody, and methods, polypeptides, polynucleotides, compositions, and vaccines related thereto.

Abstract: There are provided a fusion protein formed by coupling of anti-c-Met antibody and VEGF-binding fragment, a bispecific antibody comprising the fusion protein, a polynucleotide encoding the fusion protein, a transformant comprising the polynucleotide, a pharmaceutical composition comprising the bispecific antibody as an active ingredient, and a method for preparing the bispecific antibody which is targeted at c-Met and VEGF at the same time, with improved anticancer and anti-angiogenesis effects, comprising coupling an anti-c-Met antibody with a VEGF-binding fragment.

Abstract: An anti-c-Met antibody or antibody fragment and pharmaceutical composition comprising same, as well as a method for preventing and treating cancer by administering the antibody to a subject are provided.

Abstract: Disclosed is a method of receiving, by a terminal, an additional network service provided through a temporary base station disposed temporarily or locally in order to transfer disaster information, including: receiving information on the additional network through an existing network service provided by a base station; verifying whether the terminal is handed over to the additional network based on the information on the additional network; and receiving the additional network service through the additional network. According to the present invention, even when a communication service disability occurs due to a flood of telephone traffic in an area where a disaster situation or an event occurs, a communication service can be provided through the additional network in terms of the communication service and a broadcasting channel that provides information specific to the disaster situation or event can be temporarily or locally additionally provided.

Abstract: Provided is a method of combination therapy for prevention or treatment of c-Met-induced or angiogenesis factor-induced diseases including co-administering an angiogenesis inhibitor and an anti-c-Met antibody or an antigen-binding fragment thereof to a patient.

Abstract: Disclosed are a method and an apparatus for a scalable broadcast. The method includes scalably dividing a broadcast frequency band into segments, scalably dividing a video image into segments, and linking the segment of the broadcast frequency band to the scalably divided video image, and broadcasting the linked segments to at least one receiving apparatus.

Abstract: A broadcasting signal transmitting device transmits a broadcasting signal including a base layer signal and an enhancement layer signal as well as an additional layer signal relating to the broadcasting signal to a broadcasting signal receiving device. The broadcasting signal receiving device selectively provides the enhancement layer signal and the additional layer signal to the user according to the user's service level. Accordingly, various services are differently provided to the user according to the user level.

Abstract: Provided is a Multiple Input Multiple Output (MIMO) transmission method in a digital broadcasting system. The method includes generating a plurality of first modulation symbols by modulating first information bits; generating a plurality of second modulation symbols by modulating second information bits; generating a plurality of first pre-coded symbols and a plurality of second pre-coded symbols by pre-coding the plurality of first modulation symbols and the plurality of second modulation symbols; and allocating the plurality of first pre-coded symbols and the plurality of second pre-coded symbols staggeringly through a first antenna and a second antenna and transmitting them.

Abstract: Provided are methods and compositions for treating inflammatory autoimmune diseases in a subject comprising blocking the interaction between DR3 and TL1A. The interaction between DR3 and TL1A can be blocked by reducing expression of TL1A. The interaction between DR3 and TL1A can be blocked by administration of anti-DR3 antibodies. The interaction between DR3 and TL1A can be blocked by administration of anti-TL1A antibodies. In the methods of treating inflammatory or autoimmune disease, the inflammatory or autoimmune disease can be an autoimmune disease with a T cell component. In the methods of treating inflammatory or autoimmune disease, the inflammatory or autoimmune disease can be asthma, multiple sclerosis, rheumatoid arthritis, type 1 diabetes, graft versus host disease or inflammatory bowel disease (IBD).